FDARecalled Sep 9, 2026 · #D-0806-2026
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.
Hazard
Class II — temporary health risk
Be the first to hear about future recalls.
Add the things you own to a watchlist. We’ll alert you the moment one matches.
Get started, freeDescription
CGMP Deviations Classification: Class II Distribution: US Nationwide; Puerto Rico; and Chile.
Product details
- Product
- MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.
- Type
- Drugs
- Manufacturer
- Baxter Healthcare Corporation
- Model numbers
- NC188630, NC193719, NC194051, NC195171
- UPCs
- —